| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.32 |
8e-15 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
2e-12 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
5e-12 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.37 |
1e-11 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
3e-11 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
5e-11 |
| mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.22 |
4e-10 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
5e-10 |
| mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
5e-10 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.36 |
6e-10 |